FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014957929> ?p ?o ?g. }

• W2014957929 endingPage "11" @default.
• W2014957929 startingPage "2" @default.
• W2014957929 abstract "Glioblastoma is characterized by constitutive apoptosis resistance and survival signaling expression, but paradoxically is a necrosis-prone neoplasm. Incubation of human U118 glioblastoma cells with the antitumor alkylphospholipid analog edelfosine induced a potent necrotic cell death, whereas apoptosis was scarce. Preincubation of U118 cells with the selective MEK1/2 inhibitor U0126, which inhibits MEK1/2-mediated activation of ERK1/2, led to a switch from necrosis to caspase-dependent apoptosis following edelfosine treatment. Combined treatment of U0126 and edelfosine totally inhibited ERK1/2 phosphorylation, and led to RIPK1 and RelA/NF-κB degradation, together with a strong activation of caspase-3 and -8. This apoptotic response was accompanied by the activation of the intrinsic apoptotic pathway with mitochondrial transmembrane potential loss, Bcl-xL degradation and caspase-9 activation. Inhibition of ERK phosphorylation also led to a dramatic increase in edelfosine-induced apoptosis when the alkylphospholipid analog was used at a low micromolar range, suggesting that ERK phosphorylation acts as a potent regulator of apoptotic cell death in edelfosine-treated U118 cells. These data show that inhibition of MEK1/2-ERK1/2 signaling pathway highly potentiates edelfosine-induced apoptosis in glioblastoma U118 cells and switches the type of edelfosine-induced cell death from necrosis to apoptosis." @default.
• W2014957929 created "2016-06-24" @default.
• W2014957929 creator A5040664837 @default.
• W2014957929 creator A5043256739 @default.
• W2014957929 creator A5086834111 @default.
• W2014957929 date "2015-05-01" @default.
• W2014957929 modified "2023-10-18" @default.
• W2014957929 title "ERK1/2 acts as a switch between necrotic and apoptotic cell death in ether phospholipid edelfosine-treated glioblastoma cells" @default.
• W2014957929 cites W1575938373 @default.
• W2014957929 cites W1675058229 @default.
• W2014957929 cites W1769660510 @default.
• W2014957929 cites W1971190195 @default.
• W2014957929 cites W1971245158 @default.
• W2014957929 cites W1971592445 @default.
• W2014957929 cites W1986978728 @default.
• W2014957929 cites W1989327734 @default.
• W2014957929 cites W1995301254 @default.
• W2014957929 cites W1995910924 @default.
• W2014957929 cites W1996693710 @default.
• W2014957929 cites W1996763573 @default.
• W2014957929 cites W2010766264 @default.
• W2014957929 cites W2020568816 @default.
• W2014957929 cites W2030864103 @default.
• W2014957929 cites W2034848094 @default.
• W2014957929 cites W2036514426 @default.
• W2014957929 cites W2037380118 @default.
• W2014957929 cites W2038697002 @default.
• W2014957929 cites W2039687515 @default.
• W2014957929 cites W2039973219 @default.
• W2014957929 cites W2040829164 @default.
• W2014957929 cites W2042656641 @default.
• W2014957929 cites W2043819590 @default.
• W2014957929 cites W2047219888 @default.
• W2014957929 cites W2049605560 @default.
• W2014957929 cites W2051808238 @default.
• W2014957929 cites W2052546028 @default.
• W2014957929 cites W2054077061 @default.
• W2014957929 cites W2055878807 @default.
• W2014957929 cites W2058672828 @default.
• W2014957929 cites W2060669212 @default.
• W2014957929 cites W2066676753 @default.
• W2014957929 cites W2080368711 @default.
• W2014957929 cites W2080863182 @default.
• W2014957929 cites W2084826448 @default.
• W2014957929 cites W2086262311 @default.
• W2014957929 cites W2086785010 @default.
• W2014957929 cites W2090350928 @default.
• W2014957929 cites W2094423596 @default.
• W2014957929 cites W2095146549 @default.
• W2014957929 cites W2095435908 @default.
• W2014957929 cites W2104360930 @default.
• W2014957929 cites W2107845484 @default.
• W2014957929 cites W2114918609 @default.
• W2014957929 cites W2115992709 @default.
• W2014957929 cites W2122452009 @default.
• W2014957929 cites W2125365512 @default.
• W2014957929 cites W2131357993 @default.
• W2014957929 cites W2134807618 @default.
• W2014957929 cites W2138232240 @default.
• W2014957929 cites W2139552156 @default.
• W2014957929 cites W2149249248 @default.
• W2014957929 cites W2156748257 @default.
• W2014957929 cites W2157992516 @default.
• W2014957929 cites W2160382843 @default.
• W2014957929 cites W2171634952 @default.
• W2014957929 cites W2225803210 @default.
• W2014957929 cites W2319947100 @default.
• W2014957929 doi "https://doi.org/10.1016/j.phrs.2015.02.007" @default.
• W2014957929 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25749008" @default.
• W2014957929 hasPublicationYear "2015" @default.
• W2014957929 type Work @default.
• W2014957929 sameAs 2014957929 @default.
• W2014957929 citedByCount "17" @default.
• W2014957929 countsByYear W20149579292015 @default.
• W2014957929 countsByYear W20149579292016 @default.
• W2014957929 countsByYear W20149579292017 @default.
• W2014957929 countsByYear W20149579292018 @default.
• W2014957929 countsByYear W20149579292019 @default.
• W2014957929 countsByYear W20149579292020 @default.
• W2014957929 countsByYear W20149579292021 @default.
• W2014957929 countsByYear W20149579292022 @default.
• W2014957929 countsByYear W20149579292023 @default.
• W2014957929 crossrefType "journal-article" @default.
• W2014957929 hasAuthorship W2014957929A5040664837 @default.
• W2014957929 hasAuthorship W2014957929A5043256739 @default.
• W2014957929 hasAuthorship W2014957929A5086834111 @default.
• W2014957929 hasConcept C11960822 @default.
• W2014957929 hasConcept C185592680 @default.
• W2014957929 hasConcept C190283241 @default.
• W2014957929 hasConcept C31573885 @default.
• W2014957929 hasConcept C502942594 @default.
• W2014957929 hasConcept C503630168 @default.
• W2014957929 hasConcept C54355233 @default.
• W2014957929 hasConcept C55493867 @default.
• W2014957929 hasConcept C57074206 @default.
• W2014957929 hasConcept C86803240 @default.
• W2014957929 hasConcept C95444343 @default.
• W2014957929 hasConcept C98424977 @default.

• next